Edited Transcript of ANIP earnings conference call or presentation 6-Nov-19 3:30pm GMT [Yahoo! Finance News]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Yahoo! Finance News
Edited Transcript of ANIP earnings conference call or presentation 6-Nov-19 3:30pm GMT Our continued advancement of Cortrophin Gel. We remain on track for our supplemental NDA filing in March 2020. From our paper to practice efforts, we recently dosed our first human volunteer subjects with our finished dosage form Cortrophin Gel drug. We continue to believe that Cortrophin Gel is a transformational revenue and EBITDA opportunity for ANI. Cortrophin Gel will compete in a monopolistic market that approximates $1 billion in net revenues today. Second, a strong balance sheet and strong cash flow. Our current debt, net of cash, is approximately $130 million. At that debt level, we are levered at less than 1.5x the midpoint of our 2019 adjusted non-GAAP EBITDA guidance. Our cash flow from operations for the first 9 months of 2019 is $40.8 million, and our current cash on hand is over $64 million. A large part of the generic industry turndown in recent years can be directly attributed to ou
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ETGlobeNewswire
- GSK Announces FDA Acceptance of New Meningococcal Jab BLA [Yahoo! Finance]Yahoo! Finance
- Why ANI (ANIP) is Poised to Beat Earnings Estimates Again [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) is favoured by institutional owners who hold 64% of the company [Yahoo! Finance]Yahoo! Finance
- SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)PR Newswire
ANIP
Earnings
- 2/29/24 - Beat
ANIP
Sec Filings
- 4/18/24 - Form 144
- 4/17/24 - Form 4
- 4/17/24 - Form 144
- ANIP's page on the SEC website